Chronic Scalp Psoriasis
1 clinical trials · Condition
◉ Watch Chronic Scalp Psoriasis
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis (NCT02267135) | Novartis Pharmaceuticals | 2014-09-29 |
Track Chronic Scalp Psoriasis automatically
Every clearance here is in the API, with alerts when new ones post.